Open access
Sep 2026
Gaps in lipid management among high-risk patients without prior MI or stroke: the VESALIUS-REAL global study.
BACKGROUND Real-world evidence on lipid-lowering therapy (LLT) use and low-density lipoprotein cholesterol (LDL-C) control in patients at high cardiovascular (CV) risk without prior myocardial infarction (MI) or stroke remains limited. We evaluated LLT use, treatment intensification, LDL-C monitoring, and LDL-C goal at...
Q. Chan, J. Cegla, U. Laufs et al.
· Clinical Research in Cardiol... · 0 citations